For the press

Latest

  1. eLife invests in Texture to provide open-source content production tools for publishers

    Collaborating on the development of Texture brings eLife a step closer to its open-source, end-to-end publisher workflow.

  2. Scientists provide new insight on gene mutations associated with autism

    New research suggests increased activity in neurons that are deficient in the CNTN5 or EHMT2 gene could cause autism-related characteristics in humans.

  3. Media Coverage: January roundup of eLife papers in the news

    High-profile news coverage that eLife papers generated in January 2019, including the Telegraph, Xinhua and Science.

  4. Scientists poised to study reproducibility of Brazilian biomedical research

    The Brazilian Reproducibility Initiative will assess the replicability of biomedical science published by Brazilian institutions and explore what this literature can tell us about research reproducibility.

  5. Brain hand ‘map’ is maintained in amputees with and without phantom limb sensations

    Scientists have been able to detect the neural ‘fingerprints’ of a missing hand decades after amputation, regardless of the presence of phantom limb movements, but could not find similar fingerprints in those born with a missing hand.

  6. HIV-1 protein suppresses immune response more broadly than thought

    New insight on how an HIV-1 protein hinders the immune response to infection could inform the development of more effective treatments.

  7. Research Resource Identifiers improve proper use of cell lines in biomedical studies

    A large text-mining project suggests that including Research Resource Identifiers in scientific papers lowers incidences of problematic cell-line use.

  8. Large molecules from dietary fiber can change gut environment through physical forces

    New research on how solid particles group together in the small intestine could aid our understanding of how nutrients and drug particles are absorbed during digestion.

  9. Scientists demonstrate effective strategies for safeguarding CRISPR gene-drive experiments

    New research suggests scientists can now conduct gene-drive research in the lab without the worry of an accidental spread among a natural population.

  10. Scientists identify gene contributing to prostate cancer drug resistance

    The GREB1 gene promotes resistance to prostate cancer treatments, making it a potential target for future therapies.
Load more

Enquiries about published papers, material in press and eLife may be directed to press@elifesciences.org, or +44 1223 855373.

If you’re writing about an eLife study, please cite eLife as the source of the article and include a link to either the article or elifesciences.org, preferably using our DOI: https://doi.org/10.7554/eLife – with the article’s five-digit extension (e.g. https://doi.org/10.7554/eLife.00000). Thank you!

All content, unless otherwise stated, is available under a Creative Commons Attribution License (CC-BY). All are free to use and reuse the content provided the original source and authors are credited.

The eLife media policy encourages authors to present and discuss their works ahead of publication and indicates that eLife does not release content under embargo, except in exceptional circumstances.

Please don’t hesitate to contact us if you have any questions.